MAESTRIA-AFNET 10: Investigator Meeting in Madrid
The entire MAESTRIA – AFNET 10 team is looking forward to welcoming study sites in Madrid on 30th of August.
Search Results for: content
AFNET Lecture Award – Vortrag Prof. John Camm – DGK Jahrestagung 2025
Prof Camm was honoured with the AFNET Lecture Award at the AFNET general meeting during the DGK 2025 annual conference in Mannheim. In this document you can see his lecture at the award ceremony.
MAESTRIA Consortium Meeting, Paris: 8th and 9th May 2025
The MAESTRIA Consortium, which consists of 18 partners from different European countries, met for the 3rd time on 8 and 9 May to discuss the progress of the EU-funded MAESTRIA project.
Impressions of the 10th AFNET EHRA Consensus Conference
From May 5 to 7, 2025, the 10th AFNET EHRA Consensus Conference took place in Gressy, France. Below are some impressions of the presentations, breakout sessions and the program around it
MAESTRIA-AFNET 10 – 3rd Investigator Meeting
Beiträge AKTUELLES Mo, 07.04.2025 MAESTRIA-AFNET 10 – 3rd Investigator Meeting Prof. Goette emphasized that it is very important not only to recruit further permanent AF patients, but also to keep the patients in the study until 1-year follow up. This final data is essential to correlate it with the data from Baseline visit. All collected … Read more
Partnerstudie – EMERGE Cryo
EMERGE Cryo The “EMERGE Cryo Study” From the Emergency department directly to ablation of atrial fibrillation Study DESIGN The study is a prospective, two-arm, randomized, open-label, blinded endpoint, multicenter study to investigate the impact of first line ablation in patients presenting at the emergency room with recent-onset paroxysmal or persistent atrial fibrillation. Study objective The … Read more
Partnerstudie – EAST-STROKE
EAST-STROKE Early treatment of Atrial fibrillation for Stroke prevention Trial in acute STROKE (EAST-STROKE) STUDY DESIGN EAST-STROKE is an international, investigator-initiated, prospective, randomised, open-label study with blinded outcome assessment (PROBE design). Hypothesis The EAST-STROKE study is investigating whether early rhythm control can prevent the occurrence of cardiovascular events in patients with atrial fibrillation and acute … Read more
Partnerstudie – CABA-HFPEF
CABA-HFPEF-DZHK27 CAtheter-Based ablation of Atrial fibrillation vs. conventional treatment in patients with Heart Failure with Preserved Ejection Fraction (CABA-HFPEF) Sponsor´s Protocol Code: CABA-HFPEF-DZHK27 ClinicalTrials.gov Identifier: NCT05508256 STUDY DESIGN Investigator-initiated multicentre study with prospective parallel group comparison with randomised, open group allocation and blinded endpoint analysis (so-called PROBE design) Study objective The aim of the study … Read more
Partnerstudie – OCEAN
OCEAN The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial STUDY DESIGN Prospective, unblinded, randomised, controlled phase 4 study, international (Canada, China, Germany, Israel, Australia, Belgium), multicentre Study objective Study to investigate whether ongoing, long-term oral anticoagulation is superior to a treatment with antiplatelet therapy (ASA) alone in reducing the incidence … Read more
Partnerstudie – CLOSURE-AF-DZHK16
CLOSURE-AF-DZHK16 Left atrial appendage CLOSURE in patients with Atrial Fibrillation at high risk of stroke and bleeding compared to medical therapy: a prospective randomized clinical trial STUDY DESIGN Prospective, multi-centre, national, unblinded, randomized study. Study objective Study goal is to determine the clinical benefit of a strategy of percutaneous catheter‐based left atrial appendage (LAA) closure … Read more